277 related articles for article (PubMed ID: 26161082)
1. CD1d Expression and Invariant NKT Cell Responses in Herpesvirus Infections.
Chung BK; Priatel JJ; Tan R
Front Immunol; 2015; 6():312. PubMed ID: 26161082
[TBL] [Abstract][Full Text] [Related]
2. Functions of CD1d-Restricted Invariant Natural Killer T Cells in Antimicrobial Immunity and Potential Applications for Infection Control.
Kinjo Y; Takatsuka S; Kitano N; Kawakubo S; Abe M; Ueno K; Miyazaki Y
Front Immunol; 2018; 9():1266. PubMed ID: 29928278
[TBL] [Abstract][Full Text] [Related]
3. Hiding lipid presentation: viral interference with CD1d-restricted invariant natural killer T (iNKT) cell activation.
Horst D; Geerdink RJ; Gram AM; Stoppelenburg AJ; Ressing ME
Viruses; 2012 Oct; 4(10):2379-99. PubMed ID: 23202469
[TBL] [Abstract][Full Text] [Related]
4. Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.
Wu L; Gabriel CL; Parekh VV; Van Kaer L
Tissue Antigens; 2009 Jun; 73(6):535-45. PubMed ID: 19392798
[TBL] [Abstract][Full Text] [Related]
5. The Role of Invariant NKT in Autoimmune Liver Disease: Can Vitamin D Act as an Immunomodulator?
Smyk DS; Mavropoulos A; Mieli-Vergani G; Vergani D; Lenzi M; Bogdanos DP
Can J Gastroenterol Hepatol; 2018; 2018():8197937. PubMed ID: 30046564
[TBL] [Abstract][Full Text] [Related]
6. Identification of distinct human invariant natural killer T-cell response phenotypes to alpha-galactosylceramide.
Croudace JE; Curbishley SM; Mura M; Willcox CR; Illarionov PA; Besra GS; Adams DH; Lammas DA
BMC Immunol; 2008 Dec; 9():71. PubMed ID: 19055753
[TBL] [Abstract][Full Text] [Related]
7. Turned on by danger: activation of CD1d-restricted invariant natural killer T cells.
Lawson V
Immunology; 2012 Sep; 137(1):20-7. PubMed ID: 22734667
[TBL] [Abstract][Full Text] [Related]
8. The Response of CD1d-Restricted Invariant NKT Cells to Microbial Pathogens and Their Products.
Van Kaer L; Parekh VV; Wu L
Front Immunol; 2015; 6():226. PubMed ID: 26029211
[TBL] [Abstract][Full Text] [Related]
9. Reciprocal Crosstalk between Dendritic Cells and Natural Killer T Cells: Mechanisms and Therapeutic Potential.
Keller CW; Freigang S; Lünemann JD
Front Immunol; 2017; 8():570. PubMed ID: 28596767
[TBL] [Abstract][Full Text] [Related]
10. Invariant NKT cells facilitate cytotoxic T-cell activation via direct recognition of CD1d on T cells.
Qin Y; Oh S; Lim S; Shin JH; Yoon MS; Park SH
Exp Mol Med; 2019 Oct; 51(10):1-9. PubMed ID: 31653827
[TBL] [Abstract][Full Text] [Related]
11. The ins and outs of type I iNKT cell development.
Shissler SC; Webb TJ
Mol Immunol; 2019 Jan; 105():116-130. PubMed ID: 30502719
[TBL] [Abstract][Full Text] [Related]
12. Antigen Presentation by CD1 Lipids, T Cells, and NKT Cells in Microbial Immunity.
Cohen NR; Garg S; Brenner MB
Adv Immunol; 2009; 102():1-94. PubMed ID: 19477319
[TBL] [Abstract][Full Text] [Related]
13. Human invariant NKT cells display alloreactivity instructed by invariant TCR-CD1d interaction and killer Ig receptors.
Patterson S; Chaidos A; Neville DC; Poggi A; Butters TD; Roberts IA; Karadimitris A
J Immunol; 2008 Sep; 181(5):3268-76. PubMed ID: 18713998
[TBL] [Abstract][Full Text] [Related]
14. Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis.
Mallevaey T; Fontaine J; Breuilh L; Paget C; Castro-Keller A; Vendeville C; Capron M; Leite-de-Moraes M; Trottein F; Faveeuw C
Infect Immun; 2007 May; 75(5):2171-80. PubMed ID: 17353286
[TBL] [Abstract][Full Text] [Related]
15. Activated invariant natural killer T cells directly recognize leukemia cells in a CD1d-independent manner.
Aoki T; Takami M; Takatani T; Motoyoshi K; Ishii A; Hara A; Toyoda T; Okada R; Hino M; Koyama-Nasu R; Kiuchi M; Hirahara K; Kimura MY; Nakayama T; Shimojo N; Motohashi S
Cancer Sci; 2020 Jul; 111(7):2223-2233. PubMed ID: 32324315
[TBL] [Abstract][Full Text] [Related]
16. CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond.
King LA; Lameris R; de Gruijl TD; van der Vliet HJ
Front Immunol; 2018; 9():1519. PubMed ID: 30013569
[TBL] [Abstract][Full Text] [Related]
17. iNKT/CD1d-antitumor immunotherapy significantly increases the efficacy of therapeutic CpG/peptide-based cancer vaccine.
Corgnac S; Perret R; Zhang L; Mach JP; Romero P; Donda A
J Immunother Cancer; 2014; 2(1):39. PubMed ID: 25426294
[TBL] [Abstract][Full Text] [Related]
18. Innate immune control of EBV-infected B cells by invariant natural killer T cells.
Chung BK; Tsai K; Allan LL; Zheng DJ; Nie JC; Biggs CM; Hasan MR; Kozak FK; van den Elzen P; Priatel JJ; Tan R
Blood; 2013 Oct; 122(15):2600-8. PubMed ID: 23974196
[TBL] [Abstract][Full Text] [Related]
19. Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy.
Bedard M; Salio M; Cerundolo V
Front Immunol; 2017; 8():1829. PubMed ID: 29326711
[TBL] [Abstract][Full Text] [Related]
20. High Frequency of Gamma Interferon-Producing PLZF
Dhanushkodi NR; Srivastava R; Prakash S; Roy S; Coulon PA; Vahed H; Nguyen AM; Salazar S; Nguyen L; Amezquita C; Ye C; Nguyen V; BenMohamed L
J Virol; 2020 Apr; 94(9):. PubMed ID: 32102882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
